Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Rank in Stocks #13748
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Share Price
$3.83
Market Cap
$464.45M
Change (1 day)
-1.63%
Change (1 year)
17.17%
Country
TW
Trade Gongwin Biopharm Holdings Co., Ltd. (6617)

Category

Stock price history for Gongwin Biopharm Holdings Co., Ltd. (6617)
Highest end of day price: $3.43 on 2026-08-01

Lowest end of day price: $2.71 on 2017-02-01
Stock price history of Gongwin Biopharm Holdings Co., Ltd. from 2017 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU